Overcoming Today's Pharmaceutical Formulation Challenges with Aprecia's In-Blister Manufacturing

Tuesday, October 18, 2022

9:00 AM – 10:00 AM ET

Location:360 Stage #1, Exhibit Hall A&B

Presented By

Tech Spotlight Speaker(s)

Michael Gosselin, PhD

Vice President of Pharmaceutical Development
Aprecia
Blue Ash, Ohio

With the first FDA approval in 2015, Aprecia's latest innovation in 3D-printing technology enables tablet manufacturing directly into the primary package.

Building on Aprecia's patient friendly and patent protected ZipDose rapid dispersible formulation platform, this latest advancement provides Aprecia's licensing partners greater flexibility in material selection and formulation design to solve challenges that formulators face today. Dr. Michael Gosselin will discuss how Aprecia's technology can provide formulators solutions in areas such as fixed dose combinations, modified release formulations, solubility enhancement, micro dosing, and potent compounds.

Learning Objectives:

Upon completion, attendees will understand how Aprecia's 3D-Printing technolgy addresses challenges that face formulators today.
Attendees will understand areas of interest in applying 3D-printing for patient and caregiver benefit that can benefit their product or company.
Attendees will understand how Aprecia leverages common tableting/encapsulating excipients, materials, and intermediate manufacturing technologies to create patient friendly medications.